Vardenafil Hydrochloride Tablet
Product Images NDC 33342-153

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 33342-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardenafil-10mg-100s-bottle (Vardenafil 10mg 100s Bottle)

Label for Vardenafil Hydrochloride oral tablets, 10 mg strength, by Macleods Pharmaceuticals Limited. The label indicates a package containing 100 film-coated tablets. It includes manufacturer information for Macleods Pharma USA and Macleods Pharmaceuticals Ltd., Daman, India, with instructions to dispense an accompanying Patient Information Leaflet.*

FDA Label Image

10mg-30s (Vardenafil 10mg 30s Bottle 1)

Vardenafil Hydrochloride Tablets 10 mg oral tablets packaging label by Macleods Pharmaceuticals Limited. The label indicates 30 tablets per package, includes dosage instructions, storage conditions, and manufacturing information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The label also displays barcodes and a designated OPZ area.*

FDA Label Image

Vardenafil-10mg-carton (Vardenafil 10mg Carton)

Packaging label for Vardenafil Hydrochloride Tablets 10 mg by Macleods Pharmaceuticals Limited, marketed by Macleods Pharma USA. The label shows the product name, strength, dosage form as tablets, and packaging size of 100 tablets (10 x 10 unit dose). It includes manufacturer information, storage instructions, and a barcode.*

FDA Label Image

2-5mg-100s (Vardenafil 2 5mg 100s Bottle)

Label for Vardenafil Hydrochloride 2.5 mg oral tablets by Macleods Pharmaceuticals Limited. The label indicates the 2.5 mg strength per tablet, with packaging containing 100 tablets. It includes manufacturer information for Macleods Pharma USA in Plainsboro, NJ, and Macleods Pharmaceuticals Ltd. in India, along with dosing instructions and storage conditions.*

FDA Label Image

2.5mg-30s (Vardenafil 2 5mg 30s Bottle 1)

Label for Vardenafil Hydrochloride Tablets 2.5 mg, oral tablets in a package of 30. The label shows Macleods Pharmaceuticals Ltd. as the manufacturer and Macleods Pharma USA as the distributor, with storage instructions and dosage note. The label includes barcodes and patient information dispensing instructions.*

FDA Label Image

Vardenafil-2-5mg-carton (Vardenafil 2 5mg Carton)

Packaging label for Vardenafil Hydrochloride Tablets 2.5 mg by Macleods Pharmaceuticals Limited. The label shows the product name, strength 2.5 mg, dosage form as oral tablets, and a package size of 100 tablets (10 x 10 unit dose). Manufacturer and labeler details are included along with storage instructions and barcode.*

FDA Label Image

Vardenafil-20mg-100s-bottle (Vardenafil 20mg 100s Bottle)

Label for Vardenafil Hydrochloride tablets 20 mg by Macleods Pharmaceuticals Limited. The label notes each film-coated tablet contains vardenafil hydrochloride equivalent to 20 mg of vardenafil. It includes dosage instructions, storage conditions, and manufacturer information for Macleods Pharma USA and Macleods Pharmaceuticals Ltd. The package contains 100 oral tablets.*

FDA Label Image

20mg-30s (Vardenafil 20mg 30s Bottle 1)

Label for Vardenafil Hydrochloride Tablets 20 mg oral tablets by Macleods Pharmaceuticals Limited. The label indicates a package of 30 film-coated tablets, with storage instructions and manufacturer details for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd in India. Dosage instructions include taking one tablet daily as needed.*

FDA Label Image

Vardenafil-20mg-carton (Vardenafil 20mg Carton)

Packaging label for Vardenafil Hydrochloride Tablets 20 mg. The unit-dose package contains 50 tablets (5 x 10 unit dose) and is labeled for oral use. Manufactured by Macleods Pharmaceuticals Limited and labeled for Macleods Pharma USA, Inc. The label includes storage instructions and dosage information, with the strength prominently highlighted in green.*

FDA Label Image

Vardenafil-5mg-100s-bottle (Vardenafil 5mg 100s Bottle)

Label for Vardenafil Hydrochloride Tablets 5 mg by Macleods Pharmaceuticals Limited. The film-coated tablets contain 5 mg equivalent of Vardenafil. The label includes dosing instructions, storage conditions, and manufacturer details. The package contains 100 tablets and is marked for pharmacist dispensing with accompanying patient information.*

FDA Label Image

5mg-30s (Vardenafil 5mg 30s Bottle 1)

Label for Vardenafil Hydrochloride Tablets 5 mg, oral dosage form, manufactured by Macleods Pharmaceuticals Limited. The label shows a 30-tablet package with storage instructions and dosage information. The labeler is Macleods Pharma USA, Inc., located in Plainsboro, NJ. The product is prescription only, with NDC 33342-152-07.*

FDA Label Image

Vardenafil-5mg-carton (Vardenafil 5mg Carton)

Packaging label for Vardenafil Hydrochloride Tablets 5 mg by Macleods Pharmaceuticals Limited. The label includes the proprietary and generic name, dosage strength (5 mg), dosage form (tablet), quantity (100 tablets), manufacturer location (India), and storage instructions. The label also advises dispensing the accompanying patient information leaflet and notes the package is not child-resistant. Barcodes and batch/expiration placeholders are visible.*

FDA Label Image

Vardenafil-fig-5 (Vardenafil Fig 5)

Line graph showing mean change in mmHg over time (hours) for Vardenafil Hydrochloride tablets at 5 mg and 10 mg doses compared to placebo across two stages. The x-axis represents time in hours from 0 to 6, and the y-axis represents mean change in mmHg from -10 to 10. Four data series are plotted using different symbols for placebo (stages 1 and 2) and Vardenafil (5 mg and 10 mg).*

FDA Label Image

Vardenafil-fig-6 (Vardenafil Fig 6)

A line graph titled 'TERAZOSIN' showing mean change in mmHg (y-axis) over time in hours (x-axis) up to 6 hours. The graph compares placebo, 10 mg vardenafil, and 20 mg vardenafil treatments under two conditions: 6-hour separation and simultaneous administration, using different symbols and line styles.*

FDA Label Image

Vardenafil-fig-7 (Vardenafil Fig 7)

A line graph titled 'TAMSULOSIN' depicting mean change in blood pressure (mmHg) over time (hours) for placebo and vardenafil dosages (10 mg and 20 mg), showing data for both 6-hour separation and simultaneous administration.*

FDA Label Image

Vardenafil-fig-8 (Vardenafil Fig 8)

A line graph depicting the plasma concentration (µg/L) of Vardenafil Hydrochloride over time (hours). The graph shows a rapid increase in plasma concentration peaking within 1-2 hours, followed by a steady decline to near zero by 24 hours. Error bars indicate variability at each time point.*

FDA Label Image

Vardenafil-fig1 (Vardenafil Fig1)

A set of three line graphs showing mean maximal changes over time for systolic blood pressure, diastolic blood pressure, and heart rate in bpm. The x-axis represents timing of Vardenafil treatment pre-NTG at intervals of 24 hours, 8 hours, 4 hours, and 1 hour. The y-axes display mean maximal changes in units mmHg for blood pressures and bpm for heart rate, with data points connected by lines and error bars indicating variability.*

FDA Label Image

Vardenafil-fig2 (Vardenafil Fig2)

A line graph depicting mean change in mmHg over 6 hours comparing placebo and 5 mg vardenafil under simultaneous and 6-hour separation conditions. The y-axis shows mean change in blood pressure, while the x-axis represents time in hours. Four distinct lines with different markers illustrate the data trends for each group over time.*

FDA Label Image

Vardenafil-fig3 (Vardenafil Fig3)

A line graph showing mean change in mmHg over time (hours) comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. The x-axis represents time in hours from 0 to 6, and the y-axis shows mean change in mmHg from -15 to 15. Four data series indicated by different symbols trace the effect trends across the time points.*

FDA Label Image

Vardenafil-fig4 (Vardenafil Fig4)

A line graph depicting mean change in mmHg (y-axis) over time in hours (x-axis) for placebo and Vardenafil 10 mg and 20 mg doses across two stages. The graph shows four plotted series with placebo values fluctuating near zero, while Vardenafil doses show a decrease in mean change peaking near -8 mmHg around 2 to 4 hours before slightly rising.*

FDA Label Image

Vardenafil-str (Vardenafil Str)

Chemical structure of Vardenafil Hydrochloride, showing its molecular framework with labeled functional groups and the presence of hydrochloride trihydrate as indicated by X HCl x 3H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.